BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32593520)

  • 1. [Tocilizumab in a child with acute lymphoblastic leukaemia and COVID-19-related cytokine release syndrome].
    Velasco Puyó P; Moreno L; Díaz de Heredia C; Rivière JG; Soler Palacín P
    An Pediatr (Engl Ed); 2020 Aug; 93(2):132-133. PubMed ID: 32593520
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia.
    Ranger A; Haji R; Kaczmarski R; Danga A
    Br J Haematol; 2020 Aug; 190(3):e128-e130. PubMed ID: 32480422
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report.
    Radbel J; Narayanan N; Bhatt PJ
    Chest; 2020 Jul; 158(1):e15-e19. PubMed ID: 32343968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.
    Griffin DO; Jensen A; Khan M; Chin J; Chin K; Saad J; Parnell R; Awwad C; Patel D
    Emerg Infect Dis; 2020 Aug; 26(8):1941-1943. PubMed ID: 32348233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tocilizumab administration in a refractory case of COVID-19.
    Dastan F; Nadji SA; Saffaei A; Tabarsi P
    Int J Antimicrob Agents; 2020 Aug; 56(2):106043. PubMed ID: 32502524
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical benefits of Tocilizumab in COVID-19-related cytokine release syndrome in a patient with end-stage kidney disease on haemodialysis in Australia.
    Stephen S; Park YA; Chrysostomou A
    Nephrology (Carlton); 2020 Nov; 25(11):845-849. PubMed ID: 32776624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 in a Patient With Rheumatoid Arthritis During Tocilizumab Treatment.
    Yamada Z; Nanki T
    J Clin Rheumatol; 2020 Sep; 26(6):240-241. PubMed ID: 32732527
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 infection in children with febrile neutropenia.
    Flores V; Miranda R; Merino L; González C; Serrano C; Solano M; Herrera J; González P; Ruiz G; Saldaña R; Cárdenas A; Chávez-Aguilar LA
    Ann Hematol; 2020 Aug; 99(8):1941-1942. PubMed ID: 32529285
    [No Abstract]   [Full Text] [Related]  

  • 9. Defining the Cytokine Storm Syndrome of COVID-19: Role of the Clinical Laboratory.
    Jialal I; Devaraj S
    Ann Clin Lab Sci; 2020 Sep; 50(5):703-705. PubMed ID: 33067221
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined treatment of tocilizumab and chloroquine on severe COVID-19: a case report.
    Xu CY; Lu SD; Ye X; Cao MY; Xu GD; Yu Q; Qian JX; Zeng G
    QJM; 2020 Aug; 113(8):569-572. PubMed ID: 32365207
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab.
    Gautier-Vargas G; Baldacini C; Benotmane I; Keller N; Perrin P; Moulin B; Caillard S
    Kidney Int; 2020 Aug; 98(2):508-509. PubMed ID: 32505467
    [No Abstract]   [Full Text] [Related]  

  • 12. Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical Outcomes.
    Price CC; Altice FL; Shyr Y; Koff A; Pischel L; Goshua G; Azar MM; Mcmanus D; Chen SC; Gleeson SE; Britto CJ; Azmy V; Kaman K; Gaston DC; Davis M; Burrello T; Harris Z; Villanueva MS; Aoun-Barakat L; Kang I; Seropian S; Chupp G; Bucala R; Kaminski N; Lee AI; LoRusso PM; Topal JE; Dela Cruz C; Malinis M
    Chest; 2020 Oct; 158(4):1397-1408. PubMed ID: 32553536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of COVID-19-related cytokine storm syndrome: parallels to chimeric antigen receptor-T cell cytokine release syndrome.
    Hoiland RL; Stukas S; Cooper J; Thiara S; Chen LYC; Biggs CM; Hay K; Lee AYY; Shojania K; Abdulla A; Wellington CL; Sekhon MS
    Br J Haematol; 2020 Aug; 190(3):e150-e154. PubMed ID: 32584416
    [No Abstract]   [Full Text] [Related]  

  • 14. Colorectal surgery obesity-related morbidity during COVID-19.
    Montorfano L; Miret R; Rahman AU; Alonso M; Maron DJ; Roy M; Ferri F; Bejarano P; Wexner SD
    Surg Obes Relat Dis; 2020 Sep; 16(9):1372-1375. PubMed ID: 32723601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab.
    Balasubramanian S; Nagendran TM; Ramachandran B; Ramanan AV
    Indian Pediatr; 2020 Jul; 57(7):681-683. PubMed ID: 32393681
    [No Abstract]   [Full Text] [Related]  

  • 16. Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study.
    Ramiro S; Mostard RLM; Magro-Checa C; van Dongen CMP; Dormans T; Buijs J; Gronenschild M; de Kruif MD; van Haren EHJ; van Kraaij T; Leers MPG; Peeters R; Wong DR; Landewé RBM
    Ann Rheum Dis; 2020 Sep; 79(9):1143-1151. PubMed ID: 32719045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19).
    Nur E; Gaartman AE; van Tuijn CFJ; Tang MW; Biemond BJ
    Am J Hematol; 2020 Jun; 95(6):725-726. PubMed ID: 32267016
    [No Abstract]   [Full Text] [Related]  

  • 18. On the Alert for Cytokine Storm: Immunopathology in COVID-19.
    Henderson LA; Canna SW; Schulert GS; Volpi S; Lee PY; Kernan KF; Caricchio R; Mahmud S; Hazen MM; Halyabar O; Hoyt KJ; Han J; Grom AA; Gattorno M; Ravelli A; De Benedetti F; Behrens EM; Cron RQ; Nigrovic PA
    Arthritis Rheumatol; 2020 Jul; 72(7):1059-1063. PubMed ID: 32293098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophagocytic syndrome: a potential COVID-19 complication.
    Amaral LTW; Fonseca EKUN; Jacomelli M; Szarf G; Chate RC
    J Bras Pneumol; 2020 Sep; 46(5):e20200296. PubMed ID: 32965311
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients.
    Chen L; Long X; Xu Q; Tan J; Wang G; Cao Y; Wei J; Luo H; Zhu H; Huang L; Meng F; Huang L; Wang N; Zhou X; Zhao L; Chen X; Mao Z; Chen C; Li Z; Sun Z; Zhao J; Wang D; Huang G; Wang W; Zhou J
    Cell Mol Immunol; 2020 Sep; 17(9):992-994. PubMed ID: 32620787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.